21 – 30 of 67
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to l-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels
(
- Contribution to journal › Article
- 2011
-
Mark
Knock down of GAD67 protein levels normalizes neuronal activity in a rat model of Parkinson's disease.
(
- Contribution to journal › Article
- 2010
-
Mark
Gene Therapy for Neurological Disorders
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Adeno-associated viral vector serotypes 1 and 5 targeted to the neonatal rat and pig striatum induce widespread transgene expression in the forebrain
(
- Contribution to journal › Article
- 2009
-
Mark
L-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice
(
- Contribution to journal › Article
- 2008
-
Mark
The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons
(
- Contribution to journal › Article
- 2007
-
Mark
Expression pattern of JunD after acute or chronic l-DOPA treatment: Comparison with DeltaFosB.
(
- Contribution to journal › Article
-
Mark
The "motor complication syndrome" in rats with 6-OHDA lesions treated chronically with l-DOPA: Relation to dose and route of administration.
(
- Contribution to journal › Article
-
Mark
Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia
(
- Contribution to journal › Article
- 2006
-
Mark
Retrovirally delivered Islet-1 increases recruitment of Ng2 expressing cells from the postnatal SVZ into the striatum.
(
- Contribution to journal › Article